These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 23883971)
1. Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans. Levitsky J; Miller J; Huang X; Chandrasekaran D; Chen L; Mathew JM Transplantation; 2013 Oct; 96(8):689-96. PubMed ID: 23883971 [TBL] [Abstract][Full Text] [Related]
2. Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. Levitsky J; Gallon L; Miller J; Tambur AR; Leventhal J; Flaa C; Huang X; Sarraj B; Wang E; Mathew JM Transplantation; 2011 Jan; 91(2):199-206. PubMed ID: 21239962 [TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory Effects of Everolimus on In Vitro Alloimmune Responses. Levitsky J; Miller J; Huang X; Gallon L; Leventhal JR; Mathew JM PLoS One; 2016; 11(6):e0156535. PubMed ID: 27275747 [TBL] [Abstract][Full Text] [Related]
4. Favorable effects of alemtuzumab on allospecific regulatory T-cell generation. Levitsky J; Leventhal JR; Miller J; Huang X; Chen L; Chandrasekaran D; Tambur AR; Mathew JM Hum Immunol; 2012 Feb; 73(2):141-9. PubMed ID: 22154724 [TBL] [Abstract][Full Text] [Related]
5. The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. Levitsky J; Miller J; Leventhal J; Huang X; Flaa C; Wang E; Tambur A; Burt RK; Gallon L; Mathew JM Transplantation; 2009 Dec; 88(11):1303-11. PubMed ID: 19996930 [TBL] [Abstract][Full Text] [Related]
6. A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model. D'Addio F; Yuan X; Habicht A; Williams J; Ruzek M; Iacomini J; Turka LA; Sayegh MH; Najafian N; Ansari MJ Transplantation; 2010 Aug; 90(3):260-9. PubMed ID: 20712076 [TBL] [Abstract][Full Text] [Related]
7. Requirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR. Yu Y; Miller J; Leventhal JR; Tambur AR; Chandrasekaran D; Levitsky J; Luo X; Mathew JM PLoS One; 2011; 6(7):e22450. PubMed ID: 21799858 [TBL] [Abstract][Full Text] [Related]
8. Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans. Fanigliulo D; Lazzerini PE; Capecchi PL; Ulivieri C; Baldari CT; Laghi-Pasini F Int Immunopharmacol; 2015 Feb; 24(2):276-284. PubMed ID: 25536542 [TBL] [Abstract][Full Text] [Related]
9. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation. Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187 [TBL] [Abstract][Full Text] [Related]
11. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients. Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893 [TBL] [Abstract][Full Text] [Related]
12. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors. Mittal SK; Sharma RK; Gupta A; Naik S Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950 [TBL] [Abstract][Full Text] [Related]
13. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation. Lim DG; Koo SK; Park YH; Kim Y; Kim HM; Park CS; Kim SC; Han DJ Transplantation; 2010 Apr; 89(8):928-36. PubMed ID: 20305583 [TBL] [Abstract][Full Text] [Related]
14. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation. Wang X; Wang W; Xu J; Le Q Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787 [TBL] [Abstract][Full Text] [Related]
15. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro. Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692 [TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive drugs and Tregs: a critical evaluation! De Serres SA; Sayegh MH; Najafian N Clin J Am Soc Nephrol; 2009 Oct; 4(10):1661-9. PubMed ID: 19696218 [TBL] [Abstract][Full Text] [Related]
17. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185 [TBL] [Abstract][Full Text] [Related]
18. T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade. Grimbert P; Audard V; Diet C; Matignon M; Plonquet A; Mansour H; Desvaux D; Durrbach A; Cohen JL; Lang P Nephrol Dial Transplant; 2011 Mar; 26(3):1087-93. PubMed ID: 20667993 [TBL] [Abstract][Full Text] [Related]
19. Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil. Miroux C; Morales O; Ouaguia L; Aoudjehane L; Boleslawski E; Pancré V; de Launoit Y; Calmus Y; Conti F; Delhem N Transplant Proc; 2012 Nov; 44(9):2834-9. PubMed ID: 23146536 [TBL] [Abstract][Full Text] [Related]
20. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]